Abstract
The present study was designed to determine the antidepressant like effect of pyridoxine in mice. Pyridoxine (12.5, 25 and 50 mg/kg, i.p.) was administered to the mice and depression related behavioral and neurochemical alterations were determined. It was observed that pyridoxine (50 mg/kg, i.p.) treatment decreased the immobility period in tail suspension test (TST) and forced swim test (FST) significantly as compared to control. Pyridoxine (50 mg/kg, i.p.) treatment increased the level of serotonin (5-HT) and decreased the level of nitrite in the brain of mice significantly as compared to control. Pyridoxine thus confer antidepressant like effect by increasing the level of 5-HT and by decreasing the level of nitrite in the brain of mice. Further the influence of nitric oxide (NO)/ soluble guanylate cyclase (sGC)/ cyclic guanosine monophosphate (cGMP) in antidepressant-like effect of pyridoxine was studied. It was observed that the pretreatment of NO donor (i.e. L-Arginine) and cGMP modulator (i.e. sildenafil) counteracted while the pretreatment of NO/sGC inhibitor (i.e. methylene blue) potentiated the effect of pyridoxine in TST and FST. Pretreatment of NO donor did not influence, pretreatment of NO/sGC inhibitor decreased while the pretreatment of cGMP modulator increased the level of brain nitrite in pyridoxine treated mice. Further the pretreatment of NO donor and cGMP modulator decreased while the pretreatment of NO/sGC inhibitor increased the level of brain serotonin in pyridoxine treated mice. Pyridoxine thus exerted antidepressant like effect and NO-sGC-cGMP signaling modulated the antidepressant like effect of pyridoxine in mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The materials and the resources used was provided by the SGT University, Gurugram.
Code availability
Not applicable.
References
Allen GF, Neergheen V, Oppenheim M, Fitzgerald JC, Footitt E, Hyland K, Heales SJ (2010) Pyridoxal 5′‐phosphate deficiency causes a loss of aromatic l‐amino acid decarboxylase in patients and human neuroblastoma cells, implications for aromatic l‐amino acid decarboxylase and vitamin B6 deficiency states. J Neurochem 114(1):87–96. https://doi.org/10.1111/j.1471-4159.2010.06742.x
Almeida RC, Felisbino CS, López MG, Rodrigues ALS, Gabilan NH (2006) Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res 168:318–322. https://doi.org/10.1016/j.bbr.2005.11.023
Assaad HI, Zhou L, Carroll RJ, Wu G (2014) Rapid publication-ready MS-word tables for one-way ANOVA. Springer Plus 3:474. https://doi.org/10.1186/2193-1801-3-474
Assaad HI, Hou Y, Zhou L, Carroll RJ, Wu G (2015) Rapid publication-ready MS-word tables for two-way ANOVA. Springer Plus 4:33. https://doi.org/10.1186/s40064-015-0795-z
Baldewicz T, Goodkin K, Feaster DJ, Blaney NT, Kumar M, Kumar A, Baum M (1998) Plasma pyridoxine deficiency is related to increased psychological distress in recently bereaved homosexual men. Psychosom Med 60:297–308. https://doi.org/10.1097/00006842-199805000-00016
Bell CC (1994) DSM-IV: diagnostic and statistical manual of mental disorders. JAMA 272:828–829. https://doi.org/10.1001/jama.1994.03520100096046
Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion: enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatr 51:687–697. https://doi.org/10.1001/archpsyc.1994.03950090019003
Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355–366. https://doi.org/10.1146/annurev.med.60.042307.110802
Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004) Persistent reduction in brain serotonin 1A receptor binding in recovered depressed men measured by positron emission tomography with [11 C] WAY-100635. Mol Psychiatry 9:386–392. https://doi.org/10.1038/sj.mp.4001401
Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF (2013) Factors influencing behavior in the forced swim test. PhysiolBehav 118:227–239. https://doi.org/10.1016/j.physbeh.2013.05.012
Brigitta B (2002) Pathophysiology of depression and mechanisms of treatment. Dial Clin Neurosci 4:7–20. https://doi.org/10.31887/DCNS.2002.4.1/bbondy
Calderón-Guzmán D, Hernández-Islas JL, Espitia-Vázquez I, Barragán-Mejía G, Hernández-García E, Santamaría-del Angel D, Juárez-Olguín H (2004) Pyridoxine, regardless of serotonin levels, increases production of 5-hydroxytryptophan in rat brain. Arch Med Res 35:271–274. https://doi.org/10.1016/j.arcmed.2004.03.003
Chanrion B, La Cour CM, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Marin P (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci 104:8119–8124. https://doi.org/10.1073/pnas.0610964104
Dakshinamurti K, Paulose CS, Viswanathan M, Siow YL (1988) Neuroendocrinology of pyridoxine deficiency. NeurosciBiobehav Rev 12:189–193. https://doi.org/10.1016/s0149-7634(88)80040-x
Dakshinamurti K, Sharma SK, Bonke D (1990) Influence of B vitamins on binding properties of serotonin receptors in the CNS of rats. KlinischeWochenschrift 68:142–145. https://doi.org/10.1007/BF01646863
Dhir A, Kulkarni SK (2007a) Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog NeuroPsychopharmacol Biol Psychiatr 31:921–925. https://doi.org/10.1016/j.pnpbp.2007.02.008
Dhir A, Kulkarni SK (2007b) Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568:177–185. https://doi.org/10.1016/j.ejphar.2007.04.028
Dhir A, Kulkarni SK (2011) Nitric oxide and major depression. Nitric Oxide 24:125–131. https://doi.org/10.1016/j.niox.2011.02.002
Fasipe OJ (2018) Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Arch Med Health Sci 6:81. https://doi.org/10.4103/amhs.amhs_7_18
Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T (1997) Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatr 3:426–428. https://doi.org/10.1176/ajp.154.3.426
Ferguson JM (2001) SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clinical Psychiatry 3:22–27. https://doi.org/10.4088/pcc.v03n0105
Fossier P, Blanchard B, Ducrocq C, Leprince C, Tauc L, Baux G (1999) Nitric oxide transforms serotonin into an inactive form, and this affects neuromodulation. Neurosci 93:597–603. https://doi.org/10.1016/s0306-4522(99)00165-7
Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR (2008) Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 18:323–332. https://doi.org/10.1016/j.euroneuro.2007.07.011
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138. https://doi.org/10.1016/0003-2697(82)90118-x
Gupta G, Jia Jia T, Yee Woon L, Kumar Chellappan D, Candasamy M, Dua K (2015) Pharmacological evaluation of antidepressant-like effect of Genistein and its combination with amitriptyline: an acute and chronic study. Adv Pharmacol Sci 2015:164943. https://doi.org/10.1155/2015/164943
Ha E, Jung KH, Choe BK, Bae JH, Shin DH, Yim SV, Baik HH (2006) Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci Lett 397:185–189. https://doi.org/10.1016/j.neulet.2005.12.022
Harkin AJ, Bruce KH, Craft B, Paul IA (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1 acute treatment are active in the forced swim test. Eur J Pharmacol 372:207–213. https://doi.org/10.1016/s0014-2999(99)00191-0
Harkin A, Connor TJ, Walsh M, St John N, Kelly JP (2003) Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacol 44:616–623. https://doi.org/10.1016/s0028-3908(03)00030-3
Harkin A, Connor TJ, Burns MP, Kelly JP (2004) Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 14:274–281. https://doi.org/10.1016/j.euroneuro.2003.08.010
Harmer CJ, Cowen PJ (2013) ‘It's the way that you look at it’—a cognitive neuropsychological account of SSRI action in depression. Phil Trans R Soc B: Biol Sci 368:20120407. https://doi.org/10.1098/rstb.2012.0407
Hartvig P, Lindner KJ, Bjurling P, Laengstrom B, Tedroff J (1995) Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with positron emission tomography. J Neural Trans Gen Sec 102:91–97. https://doi.org/10.1007/BF01276505
Heckler I, Boon EM (2019) Insights into nitric oxide modulated quorum sensing pathways. Front Microbiol 10:2174. https://doi.org/10.3389/fmicb.2019.02174
Hillhouse TM, Porter JH (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1–21. https://doi.org/10.1037/a0038550
Hvas AM, Juul S, Bech P, Nexø E (2004) Vitamin B6 level is associated with symptoms of depression. PsychotherPsychosom 73:340–343. https://doi.org/10.1159/000080386
Jacobsen JP, Medvedev IO, Caron MG (2012) The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse. Philos Trans R Soc Lond Ser B Biol Sci 367(1601):2444–2459. https://doi.org/10.1098/rstb.2012.0109
James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Briggs AM (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7
Jefferys D, Funder J (1996) Nitric oxide modulates retention of immobility in the forced swimming test in rats. Eur J Pharmacol 295:131–135. https://doi.org/10.1016/0014-2999(95)00655-9
Jesse CR, Bortolatto CF, Savegnago L, Rocha JB, Nogueira CW (2008) Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog NeuroPsychopharmacol Biol Psychiatr 32:1838–1843. https://doi.org/10.1016/j.pnpbp.2008.08.010
Jesse CR, Wilhelm EA, Bortolatto CF, Rocha JB, Nogueira CW (2010) Involvement of L-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test. Eur J Pharmacol 635:135–141. https://doi.org/10.1016/j.ejphar.2010.03.019
Kaehler ST, Singewald N, Sinner C, Philippu A (1999) Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res 835:346–349. https://doi.org/10.1016/s0006-8993(99)01599-1
Khakpai F, Ebrahimi-Ghiri M, Alijanpour S, Zarrindast MR (2019) Ketamine-induced antidepressant like effects in mice: a possible involvement of cannabinoid system. Biomed Pharmacother 112:108717. https://doi.org/10.1016/j.biopha.2019.108717
Komlósi G, Molnár G, Rózsa M, Oláh S, Barzó P, Tamás G (2012) Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex. J Neurosci 32:16369–16378. https://doi.org/10.1523/JNEUROSCI.2618-12.2012
Koutsimani P, Montgomery A, Georganta K (2019) The relationship between burnout, depression, and anxiety: a systematic review and meta-analysis. Front Psychol 10:284. https://doi.org/10.3389/fpsyg.2019.00284
Krass M, Wegener G, Vasar E, Volke V (2011) The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav Brain Res 218:57–63. https://doi.org/10.1016/j.bbr.2010.11.027
Krishnan V, Nestler EJ (2011) Animal models of depression: molecular perspectives. Curr Topic Behav Neurosci 7:121–147. https://doi.org/10.1007/7854_2010_108
Kuhn DM, Arthur R (1997) Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryl’s that spare the enzyme iron center. J Neurosci 17:7245–7251. https://doi.org/10.1523/JNEUROSCI.17-19-07245.1997
Kuhn DM, Arthur RE Jr (1996) Inactivation of brain tryptophan hydroxylase by nitric oxide. J Neurochem 67:1072–1077. https://doi.org/10.1046/j.1471-4159.1996.67031072.x
Kyratsas C, Dalla C, Anderzhanova E, Polissidis A, Kokras N, Konstantinides K, Papadopoulou-Daifoti Z (2013) Experimental evidence for sildenafil's action in the central nervous system: dopamine and serotonin changes in the medial preoptic area and nucleus accumbens during sexual arousal. J Sexual Med 10:719–729. https://doi.org/10.1111/j.1743-6109.2012.03000.x
Lerner V, Miodownik C, Kaptsan A, Cohen H, Loewenthal U, Kotler M (2002) Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study. J Clin Psychiatr 63:54–58. https://doi.org/10.4088/jcp.v63n0111
Liu D, Wang Z, Liu S, Wang F, Zhao S, Hao A (2011) Anti-inflammatory effects of fluoxetine in lipopolysaccharide (LPS)-stimulated microglial cells. Neuropharmacol 61:592–599. https://doi.org/10.1016/j.neuropharm.2011.04.033
Lorrain DS, Hull EM (1993) Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 5:87–87. https://doi.org/10.1097/00001756-199310000-00024
McCarty MF (2000) High-dose pyridoxine as an 'anti-stress' strategy. Med Hyp 54:803–807. https://doi.org/10.1054/mehy.1999.0955
Mitchell NC, Gould GG, Smolik CM, Koek W, Daws LC (2013) Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: relationship with hippocampal serotonin and norepinephrine transporter expression and function. Front Pharmacol 4:131. https://doi.org/10.3389/fphar.2013.00131
Moore K, Hughes CF, Hoey L, Ward M, Cunningham C, Molloy AM, Strain JJ, Mc Carroll K, Casey C, Tracey F, Laird E, O'Kane M, McNulty H (2019) B-vitamins in relation to depression in older adults over 60 years of age: the trinity Ulster Department of Agriculture (TUDA) cohort study. J Am Med Dir Assoc 20:551–557. https://doi.org/10.1016/j.jamda.2018.11.031
Mozaffari H, Mofrad MD, Surkan PJ, Askari M, Azadbakht L (2021) Associations between dietary intake of B-vitamins and psychological disorders among Iranian women: a cross-sectional study. Pub Health Nutr 24:1787–1797. https://doi.org/10.1017/S1368980020002943
Nautiyal KM, Hen R (2017) Serotonin receptors in depression: from a to B. F1000Res 6:123. Published 2017 Feb 9. https://doi.org/10.12688/f1000research.9736.1
Ostadhadi S, Khan MI, Norouzi-Javidan A, Chamanara M, Jazaeri F, Zolfaghari S, Dehpour AR (2016) Involvement of NMDA receptors and L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test. Brain Res Bull 122:62–70. https://doi.org/10.1016/j.brainresbull.2016.03.004
Palego L, Betti L, Rossi A, Giannaccini G (2016) Tryptophan biochemistry: structural, nutritional, metabolic, and medical aspects in humans. J Amino Acids 2016:8952520. https://doi.org/10.1155/2016/8952520
Porsolt RD, Le Pichon M, Jalfre ML (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730. https://doi.org/10.1038/266730a0
Porsolt RD, Brossard G, Hautbois C, Roux S (2001) Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Prot Neurosci 14:8–10. https://doi.org/10.1002/0471142301.ns0810as14
Sachs BD, Jacobsen JPR, Thomas TL, Siesser WB, Roberts WL, Caron MG (2013) The effects of congenital brain serotonin deficiency on responses to chronic fluoxetine. Trans Psychiatr 3:e291–e291. https://doi.org/10.1038/tp.2013.65
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatr 122:509–522. https://doi.org/10.1176/ajp.122.5.509
Schlattmann P, Dirnagl U (2010) Statistics in experimental cerebrovascular research: comparison of more than two groups with a continuous outcome variable. J Cereb Blood Flow Metab 30:1558–1563. https://doi.org/10.1038/jcbfm.2010.95
Schlumpf M, Lichtensteiger W, Langemann H, Waser PG, Hefti F (1974) A fluorometric micro method for the simultaneous determination of serotonin, noradrenaline, and dopamine in milligram amounts of brain tissue. Biochem Pharmacol 23:2437–2446. https://doi.org/10.1016/0006-2952(74)90235-4
Segovia G, Porras A, Mora F (1994) Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat. Neuroreport 5:1937–1940. https://doi.org/10.1097/00001756-199410000-00024
Segovia G, Del Arco A, Mora F (1997) Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a micro dialysis study. J Neurochem 69:1476–1483. https://doi.org/10.1046/j.1471-4159.1997.69041476.x
Slattery DA, Cryan JF (2012) Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Prot 7:1009. https://doi.org/10.1038/nprot.2012.044
Smith JC, Whitton PS (2000) Nitric oxide modulates N-methyl-D-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neurosci Lett 291:5–8. https://doi.org/10.1016/s0304-3940(00)01378-1
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol 85:367–370. https://doi.org/10.1007/BF00428203
Stover PJ, Field MS (2015) Vitamin B-6. Adv Nutr 6(1):132–133. https://doi.org/10.3945/an.113.005207.P
Strasser A, McCarron RM, Ishii H, Stanimirovic D, Spatz M (1994) L-arginine induces dopamine release from the striatum in vivo. Neurorep 5:2298–2300. https://doi.org/10.1097/00001756-199411000-00023
Teegarden S (2012) Behavioral phenotyping in rats and mice. Material Method 2(122). https://doi.org/10.13070/mm.en.2.122
Trivedi MH, Wisniewski SRRA, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramanian GK, Fava M (2006) STAR* D study team: evaluation of outcomes with citalopram for depression using measurement-based care in STAR-D: implications for clinical practice. Am J Psychiatr 163:28–40. https://doi.org/10.1176/appi.ajp.163.1.28
Van der Veen FM, Evers EA, Deutz NE, Schmitt JA (2007) Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacol 32:216–224. https://doi.org/10.1038/sj.npp.1301212
Walia V, Garg C, Garg M (2018) Anxiolytic-like effect of pyridoxine in mice by elevated plus maze and light and dark box: evidence for the involvement of GABAergic and NO-sGC-cGMP pathway. Pharmacol Biochem Behav 173:96–106. https://doi.org/10.1016/j.pbb.2018.06.001
Walia V, Garg C, Garg M (2019a) Lithium potentiated, pyridoxine abolished, and fluoxetine attenuated the anxiolytic effect of diazepam in mice. Brain Res Bull 150:343–353. https://doi.org/10.1016/j.brainresbull.2019.06.008
Walia V, Garg C, Garg M (2019b) Nitrergic signaling modulation by ascorbic acid treatment is responsible for anxiolysis in mouse model of anxiety. Behav Brain Res 364:85–98. https://doi.org/10.1016/j.bbr.2019.02.007
Walia V, Garg C, Garg M (2020) Amantadine exerts anxiolytic like effect in mice: evidences for the involvement of nitrergic and GABAergic signaling pathways. Behav Brain Res 380:112432. https://doi.org/10.1016/j.bbr.2019.112432
Wegener G, Volke V (2010) Nitric oxide synthase inhibitors as antidepressants. Pharmaceuticals (Basel) 3:273–299. https://doi.org/10.3390/ph3010273
Wegener G, Volke V, Rosenberg R (2000) Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 130:575–580. https://doi.org/10.1038/sj.bjp.0703349
Wong ML, Licinio J (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3:136. https://doi.org/10.1038/nrd1303
Yankelevitch-Yahav R, Franko M, Huly A, Doron R (2015) The forced swim test as a model of depressive-like behavior. J Visual Exp 97:52587. https://doi.org/10.3791/52587
Young WB, Bradley KC, Anjum MW, Gebeline-Myers C (2013) Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study. Headache 53(9):430–1437. https://doi.org/10.1111/head.12205
Zhou QG, Zhu XH, Nemes AD, Zhu DY (2018) Neuronal nitric oxide synthase and affective disorders. IBRO Rep 5:116–132. https://doi.org/10.1016/j.ibror.2018.11.004
Zomkowski AD, Engel D, Gabilan NH, Rodrigues ALS (2010) Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur Neuropsychopharmacol 20:793–801. https://doi.org/10.1016/j.euroneuro.2010.07.011
Zomkowski AD, Engel D, Cunha MP, Gabilan NH, Rodrigues ALS (2012) The role of the NMDA receptors and L-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test. Pharmacol Biochem Behav 103:408–417. https://doi.org/10.1016/j.pbb.2012.09.011
Author information
Authors and Affiliations
Contributions
Ms. Sushma Maratha: Literature Review, Experimental work and Manuscript Writing.
Dr. Vijay Sharma: Proof-read the manuscript.
Dr. Vaibhav Walia: Study design and statistical analysis.
We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere.
We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us.
We understand that the Corresponding Author is the sole contact for the Editorial process. He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.
Corresponding author
Ethics declarations
Research ethics
The present work do not involve the human volunteer and any animal experimentation.
Conflict of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maratha, S., Sharma, V. & Walia, V. Possible involvement of NO-sGC-cGMP signaling in the antidepressant like effect of pyridoxine in mice. Metab Brain Dis 37, 173–183 (2022). https://doi.org/10.1007/s11011-021-00858-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00858-6